138 related articles for article (PubMed ID: 30310175)
1. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor.
Jour G; Vasudevaraja V; Prieto VG; Snuderl M; Torres-Cabala CA; Al-Rohil R; Sulman EP; Ballester LY; Aung PP
Mod Pathol; 2019 Mar; 32(3):338-345. PubMed ID: 30310175
[TBL] [Abstract][Full Text] [Related]
2. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
3. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.
Le Guellec S; Macagno N; Velasco V; Lamant L; Lae M; Filleron T; Malissen N; Cassagnau E; Terrier P; Chevreau C; Ranchere-Vince D; Coindre JM
Mod Pathol; 2017 Dec; 30(12):1677-1687. PubMed ID: 28752843
[TBL] [Abstract][Full Text] [Related]
4. Growth-associated protein 43 in differentiating peripheral nerve sheath tumors from other non-neural spindle cell neoplasms.
Chen WS; Chen PL; Lu D; Lind AC; Dehner LP
Mod Pathol; 2014 Feb; 27(2):184-93. PubMed ID: 23887302
[TBL] [Abstract][Full Text] [Related]
5. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas.
Jour G; Andeen NK; Al-Rohil R; Aung PP; Mehrotra M; Duose D; Hoch B; Argenyi Z; Luthra R; Wistuba II; Prieto VG
J Pathol; 2018 Jan; 244(1):97-106. PubMed ID: 28991373
[TBL] [Abstract][Full Text] [Related]
6. Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.
Thangaiah JJ; Westling BE; Roden AC; Giannini C; Tetzlaff M; Cho WC; Folpe AL
Ann Diagn Pathol; 2022 Aug; 59():151967. PubMed ID: 35567887
[TBL] [Abstract][Full Text] [Related]
7. Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.
Jackson CR; Minca EC; Kapil JP; Smith SC; Billings SD
J Cutan Pathol; 2016 Dec; 43(12):1220-1225. PubMed ID: 27687011
[TBL] [Abstract][Full Text] [Related]
8. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
[TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma.
Cruz J; Reis-Filho JS; Lopes JM
J Clin Pathol; 2004 Feb; 57(2):218-20. PubMed ID: 14747458
[TBL] [Abstract][Full Text] [Related]
10. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
11. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma.
Weissinger SE; Keil P; Silvers DN; Klaus BM; Möller P; Horst BA; Lennerz JK
Mod Pathol; 2014 Apr; 27(4):524-34. PubMed ID: 24051699
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
[TBL] [Abstract][Full Text] [Related]
13. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors.
Vougiouklakis T; Aung PP; Vasudevaraja V; Prieto VG; Torres-Cabala CA; Sulman EP; Snuderl M; Jour G
Sci Rep; 2020 Aug; 10(1):12996. PubMed ID: 32747660
[TBL] [Abstract][Full Text] [Related]
14. DNA-methylation profiling distinguishes malignant melanomas from benign nevi.
Conway K; Edmiston SN; Khondker ZS; Groben PA; Zhou X; Chu H; Kuan PF; Hao H; Carson C; Berwick M; Olilla DW; Thomas NE
Pigment Cell Melanoma Res; 2011 Apr; 24(2):352-60. PubMed ID: 21375697
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
[TBL] [Abstract][Full Text] [Related]
17. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
[TBL] [Abstract][Full Text] [Related]
18. Malignant peripheral nerve sheath tumor: pathology and genetics.
Thway K; Fisher C
Ann Diagn Pathol; 2014 Apr; 18(2):109-16. PubMed ID: 24418643
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases.
Machado I; Llombart B; Cruz J; Traves V; Requena C; Nagore E; Parafioriti A; Monteagudo C; Llombart-Bosch A
J Cutan Pathol; 2017 Jul; 44(7):632-638. PubMed ID: 28403573
[TBL] [Abstract][Full Text] [Related]
20. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology.
Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD
Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
